Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-25

Clinical Trial Update: A Study of Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD) [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluating avacopan in participants with normal renal function and those with end-stage renal disease has completed, with results posted on 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avacopan (avacopan)

Snippet

Sponsor: Amgen | Conditions: End-Stage Renal Disease (ESRD) | Phase 1 | Status: COMPLETED | Results posted: 2026-03-25